Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 14/20 | 0.51 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30740849 | 1.00 | GLP1R (0.51) | GLP1RACSS2HTR7HTR6KDM4E | |
| SCHEMBL29826381 | 0.90 | GLP1R (0.58) | GLP1R | |
| SCHEMBL29826815 | 0.85 | ACSS2 (0.46) | GLP1RACSS2HTR7HTR6KDM4E | |
| SCHEMBL30740795 | 0.85 | ACSS2 (0.46) | GLP1RACSS2HTR7HTR6KDM4E | |
| SCHEMBL29826194 | 0.85 | GLP1R (0.47) | GLP1RACSS2KDM4E | |
| SCHEMBL30740742 | 0.85 | GLP1R (0.47) | GLP1RACSS2KDM4E | |
| SCHEMBL24265338 | 0.85 | ACSS2 (0.46) | GLP1RACSS2HTR7HTR6KDM4E | |
| SCHEMBL30740718 | 0.85 | ACSS2 (0.46) | GLP1RACSS2HTR7HTR6KDM4E | |
| SCHEMBL24792073 | 0.82 | GLP1R (0.60) | GLP1R | |
| SCHEMBL24900035 | 0.81 | ACSS2 (0.47) | GLP1RACSS2HTR7HTR6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284795-A1 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Carmot Therapeutics, Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| WO-2022165076-A1 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. (US) | 2022-08-04 | — | — | WO | disclosed |